Welcome to the April issue of Contract Pharma. This month’s edition highlights critical trends and challenges shaping the pharma manufacturing and development landscape, highlighting new regulatory ...

An EO signed on April 15th is a solid first step toward improving drug affordability without diminishing the hope of patients ...

The future of aseptic small-batch manufacturing isn’t just about leading. Manufacturers who embrace automation, rethink ...

pharmaphorum looks at its evolution over the centuries. The roots of the pharmaceutical industry lie back with the apothecaries and pharmacies that offered traditional remedies as far back as the ...

In today’s fast-paced world, threats can evolve quickly and without warning. As the pharmaceutical industry has operations and supply chains spanning the globe, companies are vulnerable to ...

A team of researchers led by the University of Bonn has now identified a promising bioactive compound that could effectively ...

A medical breakthrough could result in the first treatment for rare but serious diseases in which genetic defects disrupt ...

Billionaire entrepreneur Mark Cuban backed President Donald Trump's executive order on prescription drugs and healthcare and offered his insights on reforms in the pharmaceutical industry.

He is currently in the final editing stages of his book, Financial Forecasting and Valuation: A Handbook for Academics and Practitioners, for World Scientific Press. Professor Sopranzetti (known to ...